Tatva Chintan Pharma Chem Limited (TATVA.BO)
Tatva Chintan Pharma Chem Limited operates in the Chemicals - Specialty industry of the Basic Materials sector, headquartered in Vadodara, GU, IN. The stock last traded at $1719.15, up 0.55% on the session, giving a market capitalisation of $40.11B. Its beta of 0.42 implies it has historically moved less than the broad market.
Headquartered in Vadodara, India, and founded in 1996, Tatva Chintan Pharma Chem Limited operates as a manufacturer and trader of diverse specialty chemicals. Its extensive product portfolio encompasses structure directing agents crucial for zeolite synthesis, phase transfer catalysts, and electrolyte salts utilized in supercapacitor and zinc-ion battery technologies. Additionally, the company supplies pharmaceutical active ingredients, agrochemical formulations, and various other specialized compounds such as intermediates, disinfectants, catalysts, and solvents. Tatva Chintan serves a broad spectrum of industries, including automotive, petroleum, pharmaceuticals, agrochemicals, paints and coatings, dyes and pigments, personal care, and flavor and fragrance sectors. The company maintains a global footprint, exporting its chemical solutions to several nations, notably the United States, Singapore, the United Kingdom, China, Germany, Japan, and South Africa.
Tatva Chintan Pharma Chem Limited is most often compared with the following Basic Materials names: